The Samwald research group works on strategies for high-impact interventions and risk mitigation at the interface of artificial intelligence and biomedical research / health care. Our group is part of the Section for Artificial Intelligence and Decision Support at the Medical University of Vienna, Austria.
Granted August 2015: Horizon 2020 project “Ubiquitous Pharmacogenomics (U-PGx): Making
actionable pharmacogenomic data and effective treatment optimization accessible to every
European citizen”. Role: Co-initiator, work package leader and executive board member. Total EU contribution 14,9 million €, budget for Medical University of Vienna: 1.429.783 €
Granted March 2013: FWF stand-alone project “Information technologies for clinical pharmacogenetics”, P 25608-N15. Budget: 295.942 €
Hans Kerschbaumer (masters student, medicine)
Wolfgang Kuch (masters student, medicine)
Sebastian Hofer, MSc (PhD student)
Anna Riedl (project assistant)
Paul Schrödl, BSc (masters student, computer science)
Jose Antonio Miñarro Giménez, PhD (postdoc)
Georg Petz (external masters student, computer science)
AI Strategies project
Please note that we recently launched a prototype of the AI Strategies platform which is dedicated towards finding the most impactful and beneficial ways for utilizing AI.